Pollen-food allergy syndrome and component sensitization in adolescents: A Japanese population-based study.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 22 12 2020
accepted: 22 03 2021
entrez: 14 4 2021
pubmed: 15 4 2021
medline: 30 9 2021
Statut: epublish

Résumé

Allergic rhino-conjunctivitis with pollen allergy has been prevalent worldwide and Pollen-food allergy syndrome (PFAS) refers to individuals with pollen allergy who develop oral allergy syndrome (OAS) on consuming fruits and vegetables. The prevalence of PFAS varies by region and that in Japanese adolescents remains to be elucidated. In this cross-sectional study, we examined the epidemiological characteristics of PFAS in a general population of Japanese adolescents according to pollen allergy, OAS, and IgE component sensitization. Participants comprised adolescents, at age 13 years, from a prospective birth cohort study in Japan. We administered questionnaires to collect information from parents regarding pollen allergy, PFAS and OAS at each child's age 13 years. ImmunoCAP ISAC was used to assess IgE component sensitization. Among 506 participants with a complete questionnaire and ISAC measurement results, 56.5% had a history of hay fever, 16.0% had a history of OAS, 51.0% had pollen allergy, and 11.7% had a history of PFAS; additionally, 72.7% were sensitized to one or more tree, grass, and/or weed allergens. The most common sensitization (95.7%) among adolescents with pollen allergy was to Japanese cedar (Cry j 1). The most common causal foods were kiwi and pineapple (both 39.0%). Knowledge levels about PFAS were poor among affected adolescents. We found a high prevalence of PFAS among adolescents in Japan. Although it affects approximately 1/10 adolescents in the general population, public awareness regarding PFAS is poor. Interventional strategies are needed to increase knowledge and to prevent PFAS in the general population.

Identifiants

pubmed: 33852622
doi: 10.1371/journal.pone.0249649
pii: PONE-D-20-40156
pmc: PMC8046202
doi:

Substances chimiques

Allergens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0249649

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Eur Respir J. 2004 Sep;24(3):406-12
pubmed: 15358699
PLoS One. 2014 Feb 06;9(2):e88394
pubmed: 24516646
Allergo J Int. 2015;24:320-332
pubmed: 27069843
Allergol Int. 2020 Apr;69(2):246-252
pubmed: 31708436
Ann Allergy Asthma Immunol. 2010 Mar;104(3):205-10
pubmed: 20377109
J Allergy Clin Immunol. 2018 Jan;141(1):41-58
pubmed: 29157945
Clin Exp Allergy. 1994 Apr;24(4):367-74
pubmed: 8039023
Ann Allergy Asthma Immunol. 2017 Jul;119(1):54-58
pubmed: 28668240
J Paediatr Child Health. 2014 Oct;50(10):795-800
pubmed: 24953857
Pediatr Allergy Immunol. 2018 Sep;29(6):606-611
pubmed: 29698561
Clin Allergy. 1987 Jan;17(1):33-42
pubmed: 3829369
J Allergy Clin Immunol Pract. 2020 Apr;8(4):1169-1176
pubmed: 31786255
PLoS One. 2020 Jun 9;15(6):e0234161
pubmed: 32516323
Ann Allergy Asthma Immunol. 2019 Oct;123(4):359-365
pubmed: 31376490
Allergy Asthma Immunol Res. 2018 Nov;10(6):648-661
pubmed: 30306747
J Allergy Clin Immunol Pract. 2020 Sep;8(8):2495-2504
pubmed: 32717438
Allergol Int. 2020 Oct;69(4):610-615
pubmed: 32444307
Lancet. 1998 Apr 25;351(9111):1225-32
pubmed: 9643741
J Allergy Clin Immunol. 1996 Jul;98(1):239-40
pubmed: 8765844
Allergy. 2019 Jul;74(7):1237-1248
pubmed: 30829410
Int J Tuberc Lung Dis. 2005 Jan;9(1):10-6
pubmed: 15675544
Eur Respir J. 1995 Mar;8(3):483-91
pubmed: 7789502
Ann Allergy Asthma Immunol. 2003 Sep;91(3):288-96
pubmed: 14533662
J Allergy Clin Immunol. 2000 Jul;106(1 Pt 1):27-36
pubmed: 10887301
Pediatr Allergy Immunol. 2016 May;27 Suppl 23:1-250
pubmed: 27288833
J Hum Genet. 2019 Sep;64(9):911-917
pubmed: 31249362
Auris Nasus Larynx. 2017 Aug;44(4):442-446
pubmed: 27816237
Arerugi. 1998 Aug;47(8):715-9
pubmed: 9796111
World Allergy Organ J. 2020 Feb 25;13(2):100105
pubmed: 32128024
Clin Exp Allergy. 2002 Apr;32(4):590-4
pubmed: 11972607

Auteurs

Tomoyuki Kiguchi (T)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Kiwako Yamamoto-Hanada (K)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Mayako Saito-Abe (M)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Miori Sato (M)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Makoto Irahara (M)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Hiroya Ogita (H)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Yoshitsune Miyagi (Y)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Yusuke Inuzuka (Y)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Kenji Toyokuni (K)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Koji Nishimura (K)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Fumi Ishikawa (F)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Yumiko Miyaji (Y)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Shigenori Kabashima (S)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Tatsuki Fukuie (T)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Masami Narita (M)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Yukihiro Ohya (Y)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH